Drug companies line up to make deals with Trump
Digest more
The Trump administration on Friday proposed two new programs aimed at saving Medicare billions of dollars on seniors' drugs by pegging what the government pays to prices in other developed countries.
The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing out-of-pocket drug costs under the Medicare healthcare program for older and disabled Americans to prices on par with economically comparable countries.
(The Hill) — The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved compared to last year’s spending.
Here are five ways AARP has fought to make lower drug prices a top priority. The 2003 law that created Medicare Part D included language that barred Medicare from negotiating prices with drug manufacturers. That all changed with the passage of the Inflation Reduction Act in 2022.
The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about $12 billion. So will the initiative help save money for ...
New abilities for Medicare to negotiate prescription prices mean certain drugs should be 50% to 70% cheaper for many Floridians in 2026.
U.S. President Donald Trump on Friday said he wants to meet with health insurers in coming weeks in a bid for lower prices, saying that could be another way to lower healthcare costs as millions of Americans face a potential spike in premiums.